D.E. Shaw & Co’s Ocean Biomediacal, Inc. Warrants OCEAW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-182,154
| Closed | -$4.86K | – | 4823 |
|
|
2025
Q1 | $4.86K | Hold |
182,154
| – | – | ﹤0.01% | 4160 |
|
|
2024
Q4 | $4.23K | Hold |
182,154
| – | – | ﹤0.01% | 4312 |
|
|
2024
Q3 | $8.93K | Hold |
182,154
| – | – | ﹤0.01% | 4392 |
|
|
2024
Q2 | $8.78K | Hold |
182,154
| – | – | ﹤0.01% | 4324 |
|
|
2024
Q1 | $53.2K | Hold |
182,154
| – | – | ﹤0.01% | 4050 |
|
|
2023
Q4 | $6.19K | Hold |
182,154
| – | – | ﹤0.01% | 4163 |
|
|
2023
Q3 | $27.6K | Hold |
182,154
| – | – | ﹤0.01% | 3958 |
|
|
2023
Q2 | $46.3K | Hold |
182,154
| – | – | ﹤0.01% | 3886 |
|
|
2023
Q1 | $51K | Hold |
182,154
| – | – | ﹤0.01% | 4038 |
|
|
2022
Q4 | $27.3K | Hold |
182,154
| – | – | ﹤0.01% | 4496 |
|
|
2022
Q3 | $33K | Hold |
182,154
| – | – | ﹤0.01% | 4744 |
|
|
2022
Q2 | $22K | Hold |
182,154
| – | – | ﹤0.01% | 5002 |
|
|
2022
Q1 | $45K | Sell |
182,154
-42,846
| -19% | -$13.6K | ﹤0.01% | 5163 |
|
|
2021
Q4 | $106K | Buy |
+225,000
| New | +$113K | ﹤0.01% | 5054 |
|
D.E. Shaw & Co's OCEAW Position: Q2 2025 in Review
D.E. Shaw & Co sold out of Ocean Biomediacal, Inc. Warrants (OCEAW) in Q2 2025, closing a stake of 182,154 shares — an estimated $4.86K sold.
D.E. Shaw & Co first reported a position in OCEAW in Q4 2021 and held it in 14 quarters. The position peaked at $106K in Q4 2021. 1 fund tracked by Wall St. Rank holds OCEAW as of Q2 2025.
- D.E. Shaw & Co reported no remaining Ocean Biomediacal, Inc. Warrants position as of Q2 2025 after selling out during the quarter.
- D.E. Shaw & Co sold 182,154 Ocean Biomediacal, Inc. Warrants shares in Q2 2025, an estimated $4.86K.
- D.E. Shaw & Co first reported a position in Ocean Biomediacal, Inc. Warrants in Q4 2021 and held it in 14 quarters.
- D.E. Shaw & Co's Ocean Biomediacal, Inc. Warrants position peaked at $106K in Q4 2021.
- 1 fund tracked by Wall St. Rank held Ocean Biomediacal, Inc. Warrants as of Q2 2025.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.